July 26, 2019

Click charts for enlarged versions

Portfolio Breakdown

Year-to-Date Performance

Portfolio Allocation

Positions

%

Target Position Size

Current Position Performance

Square (SQ)*

+555.44%

1st Buy 8/5/2016 @ $11.10
Current Per-Share Cost: (-$48.71)*

Boeing (BA)*

+529.38%

1st Buy 2/14/2012 @ $79.58
Current Per-Share Cost: (-$1,059.57)*

Nvidia (NVDA)

+494.46%

1st Buy 9/6/2016 @ $63.10
Current Per-Share Cost: $29.45

Apple (AAPL)*

+405.90%

1st Buy 4/18/2013 @ $56.38
Current Per-Share Cost: (-$27.78)*

Nike (NKE)*

+325.77%

1st Buy 2/14/2012 @ $26.71
Current Per-Share Cost: (-$21.94)*

Disney (DIS)*

+285.08%

1st Buy 2/14/2012 @ $41.70
Current Per-Share Cost: (-$23.30)*

IDEXX Labs (IDXX)

+185.37%

1st Buy 7/26/2017 @ $167.29
Current Per-Share Cost: $99.50

Canopy Growth (CGC)

+116.09%

1st Buy 5/24/2018 @ $29.53
Current Per-Share Cost: $17.50

IBM (IBM)

+35.74%

1st Buy 11/6/2018 @ $120.87
Current Per-Share Cost: $111.51

Salesforce.com (CRM)

+33.20%

1st Buy 6/11/2018 @ $134.05
Current Per-Share Cost: $120.10

GW Pharma (GWPH)

+28.20%

1st Buy 7/25/2018 @ $142.28
Current Per-Share Cost: $129.73

Logitech (LOGI)

+25.13%

1st Buy 11/11/2016 @ $24.20
Current Per-Share Cost: $33.01

Amazon (AMZN)

+20.25%

1st Buy 2/6/2018 @ $1,378.96
Current Per-Share Cost: $1,615.85

Citigroup (C)

+18.25%

1st Buy 10/26/2017 @ $74.06
Current Per-Share Cost: $61.02

Take Two Inter (TTWO)

+17.04%

1st Buy 7/30/2018 @ $120.99
Current Per-Share Cost: $104.05

JP Morgan (JPM)

+14.54%

1st Buy 10/26/2017 @ $102.30
Current Per-Share Cost: $101.47

Xilinx (XLNX)

+12.46%

1st Buy 5/13/2019 @ $111.57
Current Per-Share Cost: $107.39

Pfizer (PFE)

+7.82%

1st Buy 1/28/2019 @ $40.50
Current Per-Share Cost: $39.97

Kohl’s (KSS)

+6.55%

1st Buy 6/3/2019 @ $50.45
Current Per-Share Cost: $49.08

3M (MMM)

+0.93%

1st Buy 5/1/2019 @ $188.97
Current Per-Share Cost: $172.38

Dow (DOW)

-1.62%

1st Buy 5/13/2019 @ $53.18
Current Per-Share Cost: $49.92

* Indicates a position where the capital investment was sold.
Negative buy price indicates removal of investment plus additional profits.

Highlights from the Week

Biggest Winner: Kohl’s (KSS)

Kohl’s stores (KSS) bounced a significant +6.04% this week from its recent bottom on no real news. However, long-time Kohl’s holders won’t find much solace in this bounce following its selloff in excess of -40% following last quarter’s horrendous earnings report.

While my position is up +6.55% and Kohl’s does sport a 5.12% dividend yield at this  level, I only hold 1/3 of my total portfolio target allocation currently as I wait for either Kohl’s to pull back below $46 or for their next earnings report on August 20.

Biggest Loser: Boeing (BA)

Boeing (BA) reported their earnings this week, and while it should come as no surprise that the grounding of the 737-Max has negatively impacted their quarter, the company announced it might have to suspend production of the airline altogether if BA can’t get the plane off the ground.

Given the immense cost of the planes, if Boeing has to halt production, the lack of income for the company is so substantial that its loss will actually take -0.2% off the national GDP. BA sold off -8.54% on the news.

While Boeing has made me a huge amount of money in the eight years I’ve been a shareholder – I’ve sold enough of the position to take out six times my initial investment over the past year and a half – I won’t be adding back to my position again until it pulls back below $315, a drop of more than -8.5% from Friday’s $345.00 close.

Even then, I have additional targets of $269 and even $232 given the potential bad news in the stock before my position is back at its target allocation for the portfolio. 

This Week’s Moves

While I made no moves in the portfolio this week, a particularly bad news item from 3M (MMM) on Friday made me want to make readers aware of a potential closure of the position that may happen as early as Monday.

3M (MMM): Potential Closure

While 3M (MMM) gave a decent earnings report this week which initially led to a good bounce in the stock, the company announced an “internal investigation” into potential violations of the U.S. Foreign Corrupt Practices Act (FCPA) on Friday.

Apparently, 3M discovered “certain travel activities and related funding and record-keeping issues raising concerns from marketing efforts in China.”

Between the internal probe, an investigation into possible groundwater contaimination from one of its factories, and its struggles with the U.S.-China Trade War, there’s just far too much headline risk in the stock.

I’m using a stop-limit sell order slightly above my $172.38 per-share cost to close the entire position. Given the stock closed at $173.98 on Friday – less than 1.0% above my per-share cost – I don’t expect this position to stay in my portfolio for long.

Want Further Clarification?

As always, if you have questions about any of my positions or have positions of your own that you’re curious about –  feel free to leave a comment below!

See you next week!

Don't get mad, Get Irked and learn how to invest for yourself!

 

Get Irked is a small community made up of helpful, friendly and motivated investors and traders of all levels looking to reach the same goal – the ability to invest profitably in order to achieve financial independence.

Investors of ALL experience levels are welcome.

Join Get Irked by clicking here!


Disclaimer:
Eric “Irk” Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes.

As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others.

As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.